Role of copper in the onset of Alzheimer's disease compared to other metals

S Bagheri, R Squitti, T Haertlé, M Siotto… - Frontiers in aging …, 2018 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by amyloid
plaques in patients' brain tissue. The plaques are mainly made of β-amyloid peptides and …

Peptides, peptidomimetics, and carbohydrate–peptide conjugates as amyloidogenic aggregation inhibitors for Alzheimer's disease

P Ryan, B Patel, V Makwana, HR Jadhav… - ACS chemical …, 2018 - ACS Publications
Alzheimer's disease (AD) is a progressive neurodegenerative disorder accounting for 60–
80% of dementia cases. For many years, AD causality was attributed to amyloid-β (Aβ) …

Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex

LA Welikovitch, S Do Carmo, Z Maglóczky… - Acta …, 2018 - Springer
Growing evidence gathered from transgenic animal models of Alzheimer's disease (AD)
indicates that the intraneuronal accumulation of amyloid-β (Aβ) peptides is an early event in …

Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID

H Sasaguri, K Nagata, M Sekiguchi, R Fujioka… - Nature …, 2018 - nature.com
Abstract Base Editor (BE) and Target-AID (activation-induced cytidine deaminase) are
engineered genome-editing proteins composed of Cas9 and cytidine deaminases. These …

Intracellular amyloid beta expression leads to dysregulation of the mitogen-activated protein kinase and bone morphogenetic protein-2 signaling axis

E Cruz, S Kumar, L Yuan, J Arikkath, SK Batra - PloS one, 2018 - journals.plos.org
Alzheimer's disease (AD) is a neurodegenerative syndrome classically depicted by the
parenchymal accumulation of extracellular amyloid beta plaques. However, recent findings …

[HTML][HTML] Magnesium in Alzheimer's disease

D Chui, Z Chen, J Yu, H Zhang, W Wang, Y Song… - 2018 - europepmc.org
Alzheimer's disease (AD) is the most common form of dementia. It is characterized by a
progressive cognitive impairment clinically, and excessive deposits of aggregated amyloid-β …

Fighting the Cause of Alzheimer's and GNE Myopathy

S Devi, R Yadav, P Chanana, R Arya - Frontiers in Neuroscience, 2018 - frontiersin.org
Age is the common risk factor for both neurodegenerative and neuromuscular diseases.
Alzheimer disease (AD), a neurodegenerative disorder, causes dementia with age …

Assessing Cognition In A Mouse Model Of Alzheimer's Disease

JB Mels - 2018 - search.proquest.com
A major challenge in behavioural testing of Alzheimer's disease (AD) mouse models is a low
degree of standardization and translatability of tasks to humans. Bussey-Saksida …

Investigation of Monoaminergic Neurotransmitter Systems as a Method to Study Alzheimer's Disease-Related Neurodegeneration

C Gallardo - 2018 - search.proquest.com
Alzheimer's disease (AD) is the most common neurodegenerative disease and leading
cause of dementia currently afflicting 5.4 million people in the United States. Memory …

[图书][B] Development of a novel probiotic and synbiotic formulation for the management of neurodegenerative and other diseases

S Westfall - 2018 - search.proquest.com
The gut microbiota is composed of an intricate network of thousands of bacterial species
living synergistically within the gastrointestinal tract (GIT). Humans have coevolved with …